Antipsychotic Drugs Market to Reach US$ 32.83 Billion by 2032, Driven by Rising Mental Health Burden | Top Companies are Dr. Reddy's Laboratories Ltd., Otsuka Pharmaceutical Co., Ltd., Johnson & Johnson Services, Inc

The Global Antipsychotic Drugs Market reached US$ 16.41 billion in 2024 and is expected to reach US$ 32.83 billion by 2032, growing at a CAGR of 7.9% during the forecast period 2025-2032.

Antipsychotic drugs are a class of medications used to manage and treat mental health conditions such as schizophrenia, bipolar disorder, and severe depression. These drugs work by altering the effects of neurotransmitters in the brain, particularly dopamine and serotonin, to reduce symptoms like hallucinations, delusions, and mood disturbances. Antipsychotic medications are categorized into two types: typical (first-generation) and atypical (second-generation), with the latter offering improved efficacy and fewer side effects in many cases.

Get a Free Sample PDF copy of the report - https://datamintelligence.com/download-sample/antipsychotic-drugs-market?rk

Recent Developments:

United States: Recent Industry Developments

✅ In July 2025, U.S. pharmaceutical companies expanded development of long-acting injectable (LAI) antipsychotics to improve treatment adherence.
✅ In June 2025, digital therapeutics and AI-enabled monitoring tools were increasingly paired with antipsychotic therapy for personalized mental health care.
✅ In May 2025, research focused on next-generation antipsychotics with reduced metabolic and neurological side effects.

Europe: Recent Industry Developments

✅ In July 2025, European healthcare systems increased adoption of long-acting formulations to reduce relapse rates in schizophrenia patients.
✅ In June 2025, regulatory bodies supported broader access to generic atypical antipsychotics, improving affordability.
✅ In May 2025, clinical studies evaluated dual-mechanism antipsychotic drugs for better symptom control and cognitive outcomes.

Asia-Pacific: Recent Industry Developments

✅ In July 2025, China and Japan expanded community-based mental health programs integrating antipsychotic treatment.
✅ In June 2025, India increased production and export of cost-effective antipsychotic generics.
✅ In May 2025, South Korea advanced research on novel receptor-targeting antipsychotic therapies.

List of the Key Players in the Antipsychotic Drugs Market:

Dr. Reddy's Laboratories Ltd., Otsuka Pharmaceutical Co., Ltd., Johnson & Johnson Services, Inc., Teva Pharmaceutical Industries Ltd., AbbVie Inc., Alkermes, Eli Lilly and Company, Bristol-Myers Squibb Company, Sumitomo Pharma Co., Ltd. and Pfizer Inc. among others.

Segment Covered in the Antipsychotic Drugs Market:

By Drug Type: First Generation Antipsychotics, Risperidone, Quetiapine, Olanzapine, Ziprasidone, Paliperidone, Clozapine, Others, Second Generation Antipsychotics, Chlorpromazine, Flupenthixol, Afluphenazine, Haloperidol, Loxapine, Perphenazine, Pimozide, Trifluoperazine, Others, Third Generation Antipsychotics, Aripiprazole

By Indication: Schizophrenia, Dementia, Bipolar disorder, Depression, Others

By Route of Administration: Oral, Parenteral

By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Get this Premium Report: https://www.datamintelligence.com/buy-now-page?report=antipsychotic-drugs-market?rk

Regional Break out:

The global Antipsychotic Drugs Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.

☞ North America - US, Canada, Mexico

☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe

☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific

☞ South America- Brazil, Argentina, Colombia, Rest of South America

☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel

Chapter Outline:

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: key insights, key emerging trends, etc.

Chapter 3: Manufacturers competitive analysis, detailed analysis of Antipsychotic Drugs manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 5 & 6: Revenue of Antipsychotic Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: The main points and conclusions of the report.

Speak to Our Senior Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/antipsychotic-drugs-market?rk

Frequently asked questions:

➠ What is the global sales value, production value, consumption value, import and export of Antipsychotic Drugs market?

➠ Who are the global key manufacturers of the Antipsychotic Drugs Industry? How is their operating situation (capacity, production, sales, price, cost, gross, and revenue)?

➠ What are the Antipsychotic Drugs market opportunities and threats faced by the vendors in the global Antipsychotic Drugs Industry?

➠ Which application/end-user or product type may seek incremental growth prospects? What is the market share of each type and application?

➠ What focused approach and constraints are holding the Antipsychotic Drugs market?

➠ What are the different sales, marketing, and distribution channels in the global industry?

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.